The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1333
March 8, 2010
View Complete Issue         Table of Contents 2019 
Hyperbaric Oxygen Therapy for Refractory Wounds
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Hyperbaric Oxygen Therapy for Refractory Wounds
March 8, 2010 (Issue: 1333)
Hyperbaric oxygen (HBO2) therapy, breathing 100% O2 while exposed to increased atmospheric pressure, has been used for years to treat refractory wounds, especially diabetic foot ulcers.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Hyperbaric Oxygen Therapy for Refractory Wounds
Article code: 1333c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.